Stay updated on Continuous vs Intermittent Dabrafenib Plus Trametinib Clinical Trial
Sign up to get notified when there's something new on the Continuous vs Intermittent Dabrafenib Plus Trametinib Clinical Trial page.

Latest updates to the Continuous vs Intermittent Dabrafenib Plus Trametinib Clinical Trial page
- Check5 days agoChange DetectedAdded revision entry v3.3.3 to the history and removed the HHS Vulnerability Disclosure link and revision v3.3.2.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange Detected- Version history now shows a new revision v3.3.2 and removes v3.3.1 from the Study Record history. - This change reflects internal version tracking and does not modify study details or data shown to users.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision history now includes the addition of v3.3.1 and the deletion of v3.2.0 in the NCT03352947 record history.SummaryDifference0.1%

- Check41 days agoChange DetectedRemoved the government funding notice banner that warned the site may not be up to date and pointed users to opm.gov for operating status.SummaryDifference0.8%

- Check55 days agoChange DetectedThe two screenshots show the same record history page with no substantive edits to the study details or status; only caption labels differ. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference13%

Stay in the know with updates to Continuous vs Intermittent Dabrafenib Plus Trametinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Continuous vs Intermittent Dabrafenib Plus Trametinib Clinical Trial page.